Successful prenatal management of hydrops, caused by congenital cystic adenomatoid malformation, using serial aspirations

https://doi.org/10.1016/0022-3468(95)90350-XGet rights and content

Abstract

Congenital cystic adenomatoid malformation (CCAM) is a lung lesion that is now commonly diagnosed in utero with fetal ultrasonography. The described treatment of this lesion includes observation with treatment delivery, a single aspiration, thoraco-amniotic shunts, and fetal resection. This patient had an in utero diagnosis of a Stocker type I CCAM associated with hydrops. Fetal resection was not an option because of patient refusal. The fetus was treated with multiple serial aspirations. There was marked improvement of the anasarca, and subsequently the baby was born with-out respiratory distress. On the second day of life the CCAM began to expand, and the right lower lobe was resected. The baby's postoperative course was uneventful. CCAM with hydrops is associated with a high mortality rate. Current recommended therapy for these lesions is fetal resection or thoracoamniotic shunt. The authors' patient was treated with serial fetal thoracocenteses, with an excellent outcome. This therapy may be an alternative to fetal surgery or an adjunct to fetal surgery in selected cases.

References (11)

There are more references available in the full text version of this article.

Cited by (35)

  • Management of Congenital Lung Malformations

    2022, Clinics in Perinatology
  • Congenital Cystic Adenomatoid Malformation of the Lung

    2018, Obstetric Imaging: Fetal Diagnosis and Care: Second Edition
  • Congenital cystic adenomatoid malformation of the lung

    2017, Obstetric Imaging: Fetal Diagnosis and Care, 2nd Edition
  • Neonatal outcome after prenatal interventions for congenital lung lesions

    2011, Early Human Development
    Citation Excerpt :

    The largest group of congenital lung lesions treated with prenatal intervention consists of hydropic fetuses with CCAM. Treatment modalities used in macrocystic CCAM were thoracocentesis (n = 13) [18,33,49,55–60] or thoraco-amniotic shunting (n = 43) [1,6,10,36,39,42,47,50–52,57–67] (see Tables 3 and 4). In microcystic CCAM, reported treatment interventions were ultrasound guided laser coagulation or sclerosing agent injection (n = 9) [6,37,38,68,69] and resection through open fetal surgery (n = 26) [10,59,70,71] (see Tables 5 and 6).

  • Anesthesia for Intrauterine Fetal Therapy and Ex Utero Intrapartum Therapy

    2011, Advances in Anesthesia
    Citation Excerpt :

    Progression of the disease will result in fetal demise. Some examples of these diseases include twin-twin transfusion syndrome [9] or a rapidly growing lung tumor [10,11]. Hydrops fetalis is an end point that may signal the need for fetal intervention.

  • Fetal thoracic and bladder shunts

    2010, Seminars in Fetal and Neonatal Medicine
    Citation Excerpt :

    Needle drainage of the cyst is one important factor in evaluating whether thoracoamniotic shunting will significantly reduce the size of the lesion. Hence, initial macrocyst aspiration can provide helpful clinical information as it will determine the percentage mass volume decrease and therefore mass effect within the chest if the cyst were chronically drained.24–26 CCAMs with a large, dominant cyst have responded favorably to placement of a thoracoamniotic shunt.16,20,27,28

View all citing articles on Scopus

Presented at the 1994 Annual Meeting of the Section on Surgery of the American Academy of Pediatrics, Dallas, Texas, October 21–23, 1994.

View full text